3010 related articles for article (PubMed ID: 7620344)
1. Ganglioside profiles of experimental melanomas and of their melanosomal fractions.
Vedralová E; Borovanský J; Hach P
Melanoma Res; 1995 Apr; 5(2):87-92. PubMed ID: 7620344
[TBL] [Abstract][Full Text] [Related]
2. Glycosphingolipids in Bomirski transplantable melanomas in hamsters.
Ren SL; Slominski A; Yu RK
Cancer Res; 1989 Dec; 49(24 Pt 1):7051-6. PubMed ID: 2582447
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides of human melanoma.
Tsuchida T; Saxton RE; Morton DL; Irie RF
J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
[TBL] [Abstract][Full Text] [Related]
4. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
[TBL] [Abstract][Full Text] [Related]
5. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3.
Ren S; Ariga T; Scarsdale JN; Zhang Y; Slominski A; Livingston PO; Ritter G; Kushi Y; Yu RK
J Lipid Res; 1993 Sep; 34(9):1565-72. PubMed ID: 8228639
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
Ravindranath MH; Tsuchida T; Morton DL; Irie RF
Cancer; 1991 Jun; 67(12):3029-35. PubMed ID: 2044049
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
Hersey P
Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-associated gangliosides in the fish genus Xiphophorus.
Felding-Habermann B; Anders A; Dippold WG; Stallcup WB; Wiegandt H
Cancer Res; 1988 Jun; 48(12):3454-60. PubMed ID: 3370642
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
Hamilton WB; Helling F; Lloyd KO; Livingston PO
Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GD3 shedding by human malignant melanoma cells.
Bernhard H; Meyer zum Büschenfelde KH; Dippold WG
Int J Cancer; 1989 Jul; 44(1):155-60. PubMed ID: 2744885
[TBL] [Abstract][Full Text] [Related]
12. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
[TBL] [Abstract][Full Text] [Related]
13. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.
Carr A; Mazorra Z; Alonso DF; Mesa C; Valiente O; Gomez DE; Perez R; Fernandez LE
Melanoma Res; 2001 Jun; 11(3):219-27. PubMed ID: 11468510
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.
Ravindranath MH; Brazeau SM; Morton DL
Experientia; 1994 Jul; 50(7):648-53. PubMed ID: 8033972
[TBL] [Abstract][Full Text] [Related]
15. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
[TBL] [Abstract][Full Text] [Related]
16. Different sensitivities of the murine melanomas BL-6 and BL-6-beta m to local injections of interleukin-2 (IL-2). Analysis of gangliosides after the treatment.
Nakayama J; Tsuchida T; Toyofuku K; Shimokawa-Kuroki R; Taniguchi S; Hori Y
Melanoma Res; 1994 Oct; 4(5):297-302. PubMed ID: 7858413
[TBL] [Abstract][Full Text] [Related]
17. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.
Alonso DF; Gabri MR; Guthmann MD; Fainboim L; Gomez DE
Int J Oncol; 1999 Jul; 15(1):59-66. PubMed ID: 10375594
[TBL] [Abstract][Full Text] [Related]
18. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
Pukel CS; Lloyd KO; Travassos LR; Dippold WG; Oettgen HF; Old LJ
J Exp Med; 1982 Apr; 155(4):1133-47. PubMed ID: 7061953
[TBL] [Abstract][Full Text] [Related]
19. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin.
Ravindranaths MH; Paulson JC; Irie RF
J Biol Chem; 1988 Feb; 263(4):2079-86. PubMed ID: 3339003
[TBL] [Abstract][Full Text] [Related]
20. The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process.
Furukawa K; Thampoe IJ; Yamaguchi H; Lloyd KO
J Immunol; 1989 Feb; 142(3):848-54. PubMed ID: 2464027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
